GENERICally Speaking Hatch Waxman Bulletin

The Hatch-Waxman Litigation practice group at Robins Kaplan LLP is pleased to offer the latest edition of their quarterly publication regarding ANDA patent litigation issues and the generics business.

Vol. 2, No. 4

Winter 2012

Relevant court decisions highlighted in this issue:

  • AstraZeneca UK Ltd. v. Aurobindo Pharma Ltd. 
  • Hoffmann-La Roche Inc. v. Apotex Inc. 
  • In re: Fenofibrate Patent Litigation

Oren D. Langer

Partner

Managing Partner, New York Office
Member of Executive Board

Ryan M. Schultz

Partner

Pronouns: he/him

Reference Listed Drug, NDA Holder, Generic Drug Name, ANDA Applicant(s), Indication and Launch Date

Vol. 2, No. 1

Spring 2012

Vol. 2, No. 2

Summer 2012

Vol. 2, No. 3

Fall 2012